These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 12624051)

  • 1. Molecular epidemiology of Pseudomonas aeruginosa colonization in a burn unit: persistence of a multidrug-resistant clone and a silver sulfadiazine-resistant clone.
    Pirnay JP; De Vos D; Cochez C; Bilocq F; Pirson J; Struelens M; Duinslaeger L; Cornelis P; Zizi M; Vanderkelen A
    J Clin Microbiol; 2003 Mar; 41(3):1192-202. PubMed ID: 12624051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of a multidrug-resistant Pseudomonas aeruginosa clone in an intensive care burn unit.
    Hsueh PR; Teng LJ; Yang PC; Chen YC; Ho SW; Luh KT
    J Clin Microbiol; 1998 May; 36(5):1347-51. PubMed ID: 9574703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of intensive care unit relocation and role of tap water on an outbreak of Pseudomonas aeruginosa expressing OprD-mediated resistance to imipenem.
    Tran-Dinh A; Neulier C; Amara M; Nebot N; Troché G; Breton N; Zuber B; Cavelot S; Pangon B; Bedos JP; Merrer J; Grimaldi D
    J Hosp Infect; 2018 Nov; 100(3):e105-e114. PubMed ID: 29857026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The analysis of distribution of multidrug resistant Pseudomonas and Bacillus species from burn patients and burn ward environment.
    Panghal M; Singh K; Kadyan S; Chaudary U; Yadav JP
    Burns; 2015 Jun; 41(4):812-9. PubMed ID: 25468476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of interventional molecular epidemiology in controlling clonal clusters of multidrug resistant Pseudomonas aeruginosa in critically ill cancer patients.
    Adachi JA; Perego C; Graviss L; Dvorak T; Hachem R; Chemaly RF; Raad II
    Am J Infect Control; 2009 Aug; 37(6):442-6. PubMed ID: 19118923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular epidemiology of Pseudomonas aeruginosa isolated from infected ICU patients: a French multicenter 2012-2013 study.
    Slekovec C; Robert J; van der Mee-Marquet N; Berthelot P; Rogues AM; Derouin V; Cholley P; Thouverez M; Hocquet D; Bertrand X
    Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):921-926. PubMed ID: 30826996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An integrated approach to control a prolonged outbreak of multidrug-resistant Pseudomonas aeruginosa in an intensive care unit.
    Knoester M; de Boer MG; Maarleveld JJ; Claas EC; Bernards AT; de Jonge E; van Dissel JT; Veldkamp KE
    Clin Microbiol Infect; 2014 Apr; 20(4):O207-15. PubMed ID: 24707852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa.
    Deplano A; Denis O; Poirel L; Hocquet D; Nonhoff C; Byl B; Nordmann P; Vincent JL; Struelens MJ
    J Clin Microbiol; 2005 Mar; 43(3):1198-204. PubMed ID: 15750083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular epidemiological analysis of Pseudomonas aeruginosa by pulsed-field gel electrophoresis].
    Kobayasi N; Tobita M; Urayama O; Chihara J
    Rinsho Byori; 1997 Dec; 45(12):1182-6. PubMed ID: 9437901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones.
    Juan C; Zamorano L; Mena A; Albertí S; Pérez JL; Oliver A
    J Antimicrob Chemother; 2010 Mar; 65(3):474-8. PubMed ID: 20071364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas aeruginosa population structure revisited.
    Pirnay JP; Bilocq F; Pot B; Cornelis P; Zizi M; Van Eldere J; Deschaght P; Vaneechoutte M; Jennes S; Pitt T; De Vos D
    PLoS One; 2009 Nov; 4(11):e7740. PubMed ID: 19936230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular epidemiology of multidrug-resistant Pseudomonas aeruginosa in a French university hospital.
    Cholley P; Gbaguidi-Haore H; Bertrand X; Thouverez M; Plésiat P; Hocquet D; Talon D
    J Hosp Infect; 2010 Dec; 76(4):316-9. PubMed ID: 20692070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic susceptibility patterns and clones of Pseudomonas aeruginosa in Swedish ICUs.
    Erlandsson M; Gill H; Nordlinder D; Giske CG; Jonas D; Nilsson LE; Walther S; Hanberger H
    Scand J Infect Dis; 2008; 40(6-7):487-94. PubMed ID: 18584536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and resistance characteristics of Pseudomonas aeruginosa isolates from the respiratory department of a hospital in China.
    Feng W; Sun F; Wang Q; Xiong W; Qiu X; Dai X; Xia P
    J Glob Antimicrob Resist; 2017 Mar; 8():142-147. PubMed ID: 28216097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of minimum inhibitory concentrations for silver sulfadiazine and other topical antimicrobial agents against strains of Pseudomonas aeruginosa isolated from canine otitis externa.
    von Silva-Tarouca MSE; Wolf G; Mueller RS
    Vet Dermatol; 2019 Apr; 30(2):145-e42. PubMed ID: 30663140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
    Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
    Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular epidemiology of outbreaks and containment of drug-resistant Pseudomonas aeruginosa in a Tokyo hospital.
    Sekiguchi J; Teruya K; Horii K; Kuroda E; Konosaki H; Mizuguchi Y; Araake M; Kawana A; Yoshikura H; Kuratsuji T; Miyazaki H; Kirikae T
    J Infect Chemother; 2007 Dec; 13(6):418-22. PubMed ID: 18095093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraclonal variations of resistance and phenotype in Pseudomonas aeruginosa epidemic high-risk clone ST308: A key to success within a hospital?
    Abdouchakour F; Aujoulat F; Licznar-Fajardo P; Marchandin H; Toubiana M; Parer S; Lotthé A; Jumas-Bilak E
    Int J Med Microbiol; 2018 Mar; 308(2):279-289. PubMed ID: 29276044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of multidrug-resistant (MDR) Pseudomonas aeruginosa isolated in a burn center.
    de Almeida Silva KCF; Calomino MA; Deutsch G; de Castilho SR; de Paula GR; Esper LMR; Teixeira LA
    Burns; 2017 Feb; 43(1):137-143. PubMed ID: 27595453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the effectiveness of silver-coated dressing, chlorhexidine acetate (0.5%), citric acid (3%), and silver sulfadiazine (1%) for topical antibacterial effects against the multi-drug resistant Pseudomonas aeruginosa infecting full-skin thickness burn wounds on rats.
    Yabanoglu H; Basaran O; Aydogan C; Azap OK; Karakayali F; Moray G
    Int Surg; 2013; 98(4):416-23. PubMed ID: 24229034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.